Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/42/79/86/427986d7-43ae-db57-604e-2cb279213fac/mza_7407224300728278017.jpg/600x600bb.jpg
Dangerous Ideas In Drug Development
NSW Early Phase Clinical Trials Alliance (NECTA)
19 episodes
2 days ago
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
Show more...
Medicine
Health & Fitness
RSS
All content for Dangerous Ideas In Drug Development is the property of NSW Early Phase Clinical Trials Alliance (NECTA) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38424943/38424943-1744149633474-2ebf568e559a3.jpg
NECTA Meeting 2025 - Latest advances in theranostics for oncology
Dangerous Ideas In Drug Development
1 hour 3 minutes 13 seconds
7 months ago
NECTA Meeting 2025 - Latest advances in theranostics for oncology

Talk 1: Prof Louise Emmett, St Vincent’s Hospital Sydney: Latest advances in theranostics for oncology

Talk 2: Prof Shaneen Sandhu, Peter MacCallum Cancer Centre: Embedding translational science in radio medical oncology

Dangerous Ideas In Drug Development
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.